DCOY

Decoy Therapeutics Inc

May 15 • 04:00PM ET

4.41

-0.11 -2.43 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BCDA PALI SHPH BIVI TNXP

| Held by: MEDX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-124.04	Insider Own	5.56%	Shs Outstand	0.53M	Perf Week	-22.90%
Market Cap	2.35M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	0.50M	Perf Month	-24.87%
Enterprise Value	-5.47M	PEG	-	EPS next Q	-	Inst Own	0.52%	Short Float	2.26%	Perf Quarter	-50.26%
Income	-13.03M	P/S	-	EPS this Y	-	Inst Trans	0.60%	Short Ratio	0.50	Perf Half Y	-68.04%
Sales	0.00M	P/B	0.61	EPS next Y	-	ROA	-242.20%	Short Interest	0.01M	Perf YTD	-43.36%
Book/sh	7.29	P/C	0.30	EPS next 5Y	-	ROE	-661.73%	52W High	415.80 -98.94%	Perf Year	-97.12%
Cash/sh	14.67	P/FCF	-	EPS past 3/5Y	81.80% 62.32%	ROIC	-336.14%	52W Low	4.52 -2.43%	Perf 3Y	-99.79%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.49% 8.45%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	86.68%	Oper. Margin	-	ATR (14)	0.50	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	1.84	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	25.46	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.84	EPS Q/Q	97.74%	SMA20	-19.82%	Beta	0.34	Target Price	30.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-30.47%	Rel Volume	0.27	Prev Close	4.52
Employees	11	LT Debt/Eq	0.00	Earnings	Mar 30	SMA200	-83.65%	Avg Volume	22.54K	Price	4.41
IPO	Jan 29, 2015	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	5,983	Change	-2.43%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)